Skip to main content
9 October 2024
Last updated:
Wednesday 9 October 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Policy & Regulation
Policy & Regulation
GLP-1 agonist shortages set to continue
Read more
Efpia: A competitive strategy for the future
Read more
More advanced planning needed for antimicrobials
Read more
New antibiotics pass regulatory hurdles
Read more
EU prepares for expansion of biotech
Read more
FDA guidance on drugs for early Alzheimer's disease
Read more
EMA reflects on 2023
Read more
A regulatory win for a rare disease strategy
Read more
EMA adopts AI workplan
Read more
EMA launches consultation on AI
Read more
Pagination
Page 1
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form